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Conclusions: (1) The Localmed Infusion Sleeve enables drug infusion to
be uncoupled from balloon dilatation. (2) Successful delivery of Urokinase
to the vessel wall may be achieved using this device without the need for
catheter exchange. 13} Persistence of urokinase within the vessel wall occurs
after local delivery.
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Local Delivery of Urokinase to Porcine Coronary
Arteries Using the Localmed infusion Sleeve
Michael A. Azrin, Joseph F. Mitchel, Laurine M. Bow, Tod V Alberghini,
Gordon Grant, Aaron V Kaplan, David D. Waters, Raymond G. McKay. Hartford
Hospital, Hartford, CT; University of Connecb'cut, Farmington, CT
this device, 1231-urokinase was delivered to 19 coronary arteries in 10 anes-
thetized pigs. All vessels underwent dilation at 6 atm, with simultaneous in-
fusion of urokinase. Drug was infused at an inflation pressure of 2 or 4 atm,
a balloon:artery ratio of either 1:1 or 1.2:1. and at a concentration of either
5,500 or 11,000 units/ml. Treated vessels were harvested up to 5 hrs later to
quantitate intramural drug deposition and washout.
Results: Successful drug delivery was accomplished in all vessels without
adverse hemodynamic, electrical, or angiographic sequelae. The efficiency
of drug delivery (i.e., % of delivered drug that was intramurally deposited)
ranged from 0.06 to 0.4%. Drug infusion pressure had no significant effect on
drug deposition. Higher urokinase concentrations and a higher balloon :artery
ratio resulted in higher intramural drug levels (p < 0.01). Urokinase deposition
and washout is described below:
Conclusions: Urokinase can be safely delivered at coronary angioplasty
sites using the Channelled balloon. Intramural drug deposition is related to
the concentration of infused drug and balloon:artery ratio. Although signif-
icant washout occurs, urokinase persists for at least 5 hours following de-
livery. This technique may be useful in the local dissolution of intracoronary
thrombus and creates a reservoir of urokinase at an angioplasty site which
may result in prolonged local thrombolysis.
Local Delivery of thrombolytic agents may reduce thrombus formation after
balloon angioplasty. The Localmed Infusion Sleeve enables localized infusion
of urokinase to be performed at the time of balloon angioplasty without the
need for catheter exchange. Methods: Balloon angioplasty was performed
on 13 coronary arteries of 5 pigs at 4 atmospheres with a balloon to artery
ratio of approximately 1.1 to 1. After angioplasty the Infusion Sleeve was
advanced over the dilatation balloon and the balloon was reinflated to 2 at-
mospheres to appose the sleeve to the vessel wall. 50,000 Units (8 ccl of
1231-urokinase was infused through the microperforations in the sleeve for
10 seconds by a computer controlled pump. The coronaries were then ex-
cised and counted in a gamma counter.
Results:
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PTCA in the setting of unstable angina (UA) and coronary thrombus (CT) is as-
sociated with adverse outcomes. We performed a pilot study of intralesional
tPA (20 mg) using an end-hole infusion (Tracker) catheter and intracoronary
heparin 15,000 units). delivered over 20 mins, prior to PTCA in 53 pts with
11001-241
11001-251
197
96.1 ± 1.6'
70.7 ± 4.5'
900-138045Q..-B99
656
83.3 ± 20
52.9 ± 27
178
76.5 ± 40
42.8 ± 48
40-449
Exercise Performance Predicts Long-term
Prognosis in Patients with PTCA for Multivessel
Disease
# Kaplan-Meier, 'p = 0.0000 by log-rank test
Age >= 65 (N = 154) Age < 651N ~ 290) p-value
% Imean) % (mean)
Age (years) 169.7) (53.91 0000
Male Gender 51.9 73.8 0000
Never Smoked 39.0 266 0.007
Prior MI 35.7 328 0.531
Hypertension 46.7 355 0.023
Non-O-Wave MI 31.4 403 0.063
Abnormal ECG 92.9 94.1 0597
LV EF (613) (58.7) 0038
2-3 Vessel Disease 50.0 36.0 0005
Angiographic Success 95.5 96.4 0.689
Events by 42 days
Death 1.3 14 0.938
MI 6.5 55 0.671
Stroke 0.0 0.3 0463
CABG 1.3 4.2 0.102
Death/MllStroke/CABG 8.4 9.0 0864
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In comparison to younger pts., elderly pts having PTCA in TIMIIIIB were
more often female, had not smoked, had history of hypertension and had
multivessel coronary disease. The results of PTCA were equally excellent in
both groups. Thus, advanced age alone does not adversely affect the results
of PTCA in selected pts with acute ischemic syndromes.
Christoph Kadel, Andrea Wolf, Rainer Schrader. University Hospital Frankfurt am
Main FRG
The aim of the study was to evaluate whether exercise performance
(watts*minl close to the time of PTCA predicts long-term prognosis in P with
multivessel disease (MVD). 1031 (study group) of 1252 consecutive P with
MVD and PTCA during 1977-90 underwent an exercise ECG. Exercise was
performed with a constantly maintained workload and terminated at severe
angina, ST.j, ;::3 mm, or at 6 min. Completeness of revascularization was
established by reangiograms in 564n96 successful P. Long-term follow-up,
ascertained by questionnaire in 97.9%, ranged from 2-15 (median 4.8) yrs.
Results. Univariate analyses revealed a strong correlation between exer-
cise performance and long-term prognosis:
Cox's multivariate regression determined exercise performance as the
most important predictor of long-term survival, p = 0.0000, followed by 3VD,
P = 0.001, and age, p = 0.01. Survival without MI or CABG was predicted
by completeness of revascularization, exercise performance, and acute suc-
cess, each p = 0.0000, and by 3VD, P = 0.02.
Conclusion. The functional parameter of exercise performance was a more
powerful predictor of long-term survival after PTCA in P with MVD than angio-
graphic parameters such as 3VD or completeness of revascularization and
therefore should be considered, if algorithms for estimation of long-term
outcome are designed.
The Channelled Balloon is a new local drug delivery catheter which allows for
simultaneous vessel dilation and local drug infusion at low pressure. In or-
der to assess the pharmacokinetics of intracoronary urokinase delivery with
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